Reata Pharmaceuticals

About:

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

Website: http://www.reatapharma.com

Twitter/X: reatapharma

Top Investors: Novo Holdings, Silicon Valley Bank, The University of Texas at Austin, Blackstone Life Sciences, CPMG

Description:

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases. It offers antioxidant and inflammation-modulating drugs, as well as drugs that correct protein misfolding. The company also develops drugs for the treatment of renal, cardiovascular, and autoimmune diseases. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005.

Total Funding Amount:

$2.01B

Headquarters Location:

Irving, Texas, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)reatapharma.com

Founders:

Warren Huff

Number of Employees:

251-500

Last Funding Date:

2023-05-10

IPO Status:

Public

© 2025 bioDAO.ai